Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

Dave Kappos Authors Article Examining Patent Infringement for Law360

February 07, 2023

Cravath partner David J. Kappos and USC Gould School of Law Professor Jonathan Barnett co‑authored an article entitled “Enhanced Damages Necessary In No‑Injunction Patent System,” which was published to the website of Law360 on February 2, 2023. The authors explore the U.S. Supreme Court’s 2006 decision in eBay, Inc. v. MercExchange, LLC, which they conclude created an environment of “efficient” patent infringement, in which litigating is more cost‑effective for infringers than paying royalties at the outset. They propose expanding the use of enhanced infringement damages to disincentivize infringement and restore balance at the license negotiating table.

Please click here to read the full article.

Related Practices & Industries

  • Corporate
  • Litigation
  • Intellectual Property
  • Intellectual Property Litigation
  • Technology

Authors

Photo
Name
David J. Kappos
Title
Corporate
Title
Partner
Email
dkappos@cravath.com
Phone
+1-212-474-1168
vCard
Download vCard

    Education

    • J.D., 1990, University of California, Berkeley, School of Law
    • B.S., 1983, University of California, Davis
      summa cum laude

    Admitted In

    • New York
    • California
    • District of Columbia

    Related News & Insights

    Deals & Cases

    February 06, 2023

    RedHill’s Agreement with HealthCare Royalty to Extinguish its Debt Obligations in Exchange for Movantik®

    On February 6, 2023, RedHill Biopharma Ltd. (“RedHill”), a specialty biopharmaceutical company, announced the extinguishment of all RedHill’s debt obligations (including all principal, interest, revenue interest, prepayment premiums and exit fees) under the Credit Agreement between RedHill’s U.S. subsidiary RedHill Biopharma Inc. and HealthCare Royalty (“HCR”) dated February 23, 2020 (as amended) in exchange for the transfer of its rights in Movantik® (naloxegol) to Movantik Acquisition Co., an affiliate of HCR. Cravath is representing RedHill in connection with the transaction.

    Deals & Cases

    January 25, 2023

    WiseTech Global’s Acquisition of Envase Technologies

    On January 24, 2023, WiseTech Global, developer of leading logistics execution software CargoWise, announced its acquisition of Envase Technologies (“Envase”), a leading provider of transport management system software for intermodal trucking, drayage (container haulage) and landside logistics in North America, in a transaction valued at $230 million. Envase is being acquired from private investment firm and supply chain investor Firmament, and a small number of other sellers. Cravath is representing WiseTech Global in connection with the transaction.

    Deals & Cases

    November 07, 2022

    Viatris’ Acquisitions of Oyster Point and Famy Life Sciences

    On November 7, 2022, Viatris Inc. (“Viatris”), a global healthcare company, announced it intends to create an ophthalmology franchise by acquiring Oyster Point Pharma (“Oyster Point”) and Famy Life Sciences.

    Deals & Cases

    October 11, 2022

    Brookfield Renewable and Cameco’s $7.875 Billion Acquisition of Westinghouse

    On October 11, 2022, Brookfield Renewable Partners (“Brookfield Renewable”), together with its institutional partners and Cameco Corporation (“Cameco”), announced they are forming a strategic partnership (“the consortium”) to acquire Westinghouse Electric Company (“Westinghouse”), one of the world’s largest nuclear services businesses, for a total enterprise value of $7.875 billion.

    Cravath Bicentennial

    Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

    Explore

    Cravath, Swaine & Moore LLP Logo
    • CONTACT US
    • OUR STORY
    • ALUMNI PORTAL
    • DISCLAIMERS & NOTICES

    Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.